| Literature DB >> 31497592 |
Abstract
The catechol quinone (CQ) motif is present in many biologically relevant molecules throughout endogenous metabolic products, foods, drugs, and environmental pollutants. The CQ derivatives may undergo Michael addition, and has been shown to yield covalent bonds with nucleophilic sites of cysteine, lysine, or histidine residue of proteins. The CQ-adducted proteins may exhibit cytotoxicity or biological functions different from their un-adducted forms. Identification, characterization, and quantification of relevant protein targets are essential but challenging goals. Mass spectrometry (MS) is well-suited for the analysis of proteins and protein modifications. Technical development of bottom-up proteomics has greatly advanced the field of biomolecular MS, including protein adductomics. This mini-review focuses on the use of biomolecular MS in (1) structural and functional characterization of CQ adduction on standards of proteins, (2) identification of endogenous adduction targets, and (3) quantification of adducted blood proteins as exposure index. The reactivity and outcome of CQ adduction are discussed with emphases on endogenous species, such as dopamine and catechol estrogens. Limitations and advancements in sample preparation, MS instrumentation, and software to facilitate protein adductomics are also discussed.Entities:
Keywords: adductomics; biomolecular mass spectrometry; catechol; catechol quinone; parallel reaction monitoring; protein adduction; quinone; selective reaction monitoring
Year: 2019 PMID: 31497592 PMCID: PMC6712063 DOI: 10.3389/fchem.2019.00571
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
Figure 1Two main reactions of catechol quinone.
Structural and functional characterization of CQ adduction on protein standards involving MS.
| Glutathione (Cys) | Quercetin quinone methide, 4-methyl-1,2-benzoquinone, 4-methylcatechol | MALDI-MS | Cheynier et al., |
| BSA | Chlorogenic acid, 4-methyl-1,2-benzoquinone, 4-methylcatechol | LC-ESI-MS | Rawel et al., |
| α-Lactalbumin | Chlorogenic acid | MALDI-MS | Prigent et al., |
| Lysozyme | Chlorogenic acid | MALDI-MS | Prigent et al., |
| Myoglobin | o-Hydroxybenzene, gallic acid | MALDI-MS | Kroll and Rawel, |
| GAPDH (Cys 152 | Green tea polyphenol (–)-epigallocatechin-3-gallate (EGCG) | MALDI/TOF | Ishii et al., |
| Neuroglobin (Cys46, Cys55, and Cys120) | Catecholamines (dopamine, norepinephrine) and catechol estrogens (2-hydroxyestradiol and 4-hydroxyestradiol) | LC-ESI-MS2 | Nicolis et al., |
| Insulin (Cys 7A, Cys 7B, His 10B, Lys 29B) | Catechol estrogens (4-hydroxyestradiol) | LC-ESI-MS2 | Ku et al., |
| Cytochrome c (Cys 102, Lys7, Lys25, Lys39, Lys72, Lys87, and Lys88) | Benzoquinone, 2-( | MALDI-MS LC-ESI-MS2 | Guo et al., |
| Hemoglobin (N-termini, Lys62, α-Cys104, β-Cys93) | 1,2- and 1,4-naphthoquinones, dopamine | LC-ESI-MS2 LC-MS2 including photodissociation | Zhang and Bartels, |
Identified by mutation.